Bioorganic and Medicinal Chemistry Letters, volume 27, issue 2, pages 261-265

Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility

Publication typeJournal Article
Publication date2017-01-01
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor2.7
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
The current optimization of IG-105 (3) on the carbazole-ring provided a series of new carbazole sulfonamides derivatives 13a-13m. All of the compounds have been evaluated against HepG2 cells (hepatoma cancer) for antiproliferative activity. Compounds that showed activity better or comparable to that of 3 versus HepG2 were evaluated against MCF-7 (breast cancer), MIA PaCa-2 (pancreatic cancer), and Bel-7402 (hepatoma/liver cancer) for antiproliferative activity. Of the seven compounds selected for further study five (13b, 13g, 13j, 13k and 13l) were found to give IC50 values against the four cell lines comparable to those for 3. Two compounds (13f and 13i) were more active than 3 and their activity against HepG2 and MCF-7 (IC50:0.01-0.07μM) approached that of the positive controls podophyllotoxin (podo) and CA-4. Most of compounds showed aqueous solubility (0.11-19.60μg/mL at pH 7.4 and 2.0) better than 3. These promising results warrant further development of new compounds 13f and 13i as potential potent antitumor drug candidates.

Citations by journals

1
2
3
4
Journal of Molecular Structure
Journal of Molecular Structure, 4, 14.81%
Journal of Molecular Structure
4 publications, 14.81%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2, 7.41%
European Journal of Medicinal Chemistry
2 publications, 7.41%
Anti-Infective Agents
Anti-Infective Agents, 1, 3.7%
Anti-Infective Agents
1 publication, 3.7%
Pharmaceuticals
Pharmaceuticals, 1, 3.7%
Pharmaceuticals
1 publication, 3.7%
Molecules
Molecules, 1, 3.7%
Molecules
1 publication, 3.7%
Frontiers in Chemistry
Frontiers in Chemistry, 1, 3.7%
Frontiers in Chemistry
1 publication, 3.7%
Bioorganic Chemistry
Bioorganic Chemistry, 1, 3.7%
Bioorganic Chemistry
1 publication, 3.7%
Heliyon
Heliyon, 1, 3.7%
Heliyon
1 publication, 3.7%
Cancer Letters
Cancer Letters, 1, 3.7%
Cancer Letters
1 publication, 3.7%
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 1, 3.7%
Bioorganic and Medicinal Chemistry Letters
1 publication, 3.7%
Chemical Biology and Drug Design
Chemical Biology and Drug Design, 1, 3.7%
Chemical Biology and Drug Design
1 publication, 3.7%
Journal of Heterocyclic Chemistry
Journal of Heterocyclic Chemistry, 1, 3.7%
Journal of Heterocyclic Chemistry
1 publication, 3.7%
ChemistrySelect
ChemistrySelect, 1, 3.7%
ChemistrySelect
1 publication, 3.7%
Chemistry - A European Journal
Chemistry - A European Journal, 1, 3.7%
Chemistry - A European Journal
1 publication, 3.7%
Journal of Chemical Information and Modeling
Journal of Chemical Information and Modeling, 1, 3.7%
Journal of Chemical Information and Modeling
1 publication, 3.7%
Journal of Agricultural and Food Chemistry
Journal of Agricultural and Food Chemistry, 1, 3.7%
Journal of Agricultural and Food Chemistry
1 publication, 3.7%
Russian Journal of Bioorganic Chemistry
Russian Journal of Bioorganic Chemistry, 1, 3.7%
Russian Journal of Bioorganic Chemistry
1 publication, 3.7%
Russian Journal of Physical Chemistry A
Russian Journal of Physical Chemistry A, 1, 3.7%
Russian Journal of Physical Chemistry A
1 publication, 3.7%
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, 1, 3.7%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 3.7%
Polycyclic Aromatic Compounds
Polycyclic Aromatic Compounds, 1, 3.7%
Polycyclic Aromatic Compounds
1 publication, 3.7%
Synthesis
Synthesis, 1, 3.7%
Synthesis
1 publication, 3.7%
Current Medicinal Chemistry
Current Medicinal Chemistry, 1, 3.7%
Current Medicinal Chemistry
1 publication, 3.7%
Future Medicinal Chemistry
Future Medicinal Chemistry, 1, 3.7%
Future Medicinal Chemistry
1 publication, 3.7%
1
2
3
4

Citations by publishers

2
4
6
8
10
Elsevier
Elsevier, 10, 37.04%
Elsevier
10 publications, 37.04%
Wiley
Wiley, 4, 14.81%
Wiley
4 publications, 14.81%
Bentham Science
Bentham Science, 2, 7.41%
Bentham Science
2 publications, 7.41%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 2, 7.41%
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 7.41%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 7.41%
American Chemical Society (ACS)
2 publications, 7.41%
Pleiades Publishing
Pleiades Publishing, 2, 7.41%
Pleiades Publishing
2 publications, 7.41%
Taylor & Francis
Taylor & Francis, 2, 7.41%
Taylor & Francis
2 publications, 7.41%
Frontiers Media S.A.
Frontiers Media S.A., 1, 3.7%
Frontiers Media S.A.
1 publication, 3.7%
Thieme
Thieme, 1, 3.7%
Thieme
1 publication, 3.7%
Future Medicine
Future Medicine, 1, 3.7%
Future Medicine
1 publication, 3.7%
2
4
6
8
10
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Sun L. et al. Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility // Bioorganic and Medicinal Chemistry Letters. 2017. Vol. 27. No. 2. pp. 261-265.
GOST all authors (up to 50) Copy
Sun L., Wu Y., Liu Y., Chen X., Hu L. Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility // Bioorganic and Medicinal Chemistry Letters. 2017. Vol. 27. No. 2. pp. 261-265.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmcl.2016.11.068
UR - https://doi.org/10.1016%2Fj.bmcl.2016.11.068
TI - Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Sun, Lianqi
AU - Wu, Yanbin
AU - Liu, Yonghua
AU - Chen, Xiaofang
AU - Hu, Laixing
PY - 2017
DA - 2017/01/01 00:00:00
PB - Elsevier
SP - 261-265
IS - 2
VL - 27
SN - 0960-894X
SN - 1464-3405
ER -
BibTex |
Cite this
BibTex Copy
@article{2017_Sun,
author = {Lianqi Sun and Yanbin Wu and Yonghua Liu and Xiaofang Chen and Laixing Hu},
title = {Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2017},
volume = {27},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016%2Fj.bmcl.2016.11.068},
number = {2},
pages = {261--265},
doi = {10.1016/j.bmcl.2016.11.068}
}
MLA
Cite this
MLA Copy
Sun, Lianqi, et al. “Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility.” Bioorganic and Medicinal Chemistry Letters, vol. 27, no. 2, Jan. 2017, pp. 261-265. https://doi.org/10.1016%2Fj.bmcl.2016.11.068.
Found error?